{"id":8154,"date":"2026-07-08T07:25:48","date_gmt":"2026-07-08T07:25:48","guid":{"rendered":"https:\/\/chemsaxis.com\/?p=8154"},"modified":"2026-07-18T06:06:37","modified_gmt":"2026-07-18T06:06:37","slug":"buy-emylcamate","status":"publish","type":"post","link":"https:\/\/chemsaxis.com\/fr\/buy-emylcamate\/","title":{"rendered":"\u00c9mylcamate"},"content":{"rendered":"
\"Buy<\/a>
Emylcamate<\/figcaption><\/figure>\n

Buy emylcamate online | Wholesale emylcamate<\/span><\/h1>\n

Buy Emylcamate, which is an anxiolytic and muscle relaxant, first synthesized in 1961 and immediately patented in the USA and used in medicine for the treatment of anxiety and tension. Emylcamate has also been used to treat alcohol addiction. Emylcamate has sedative, anxiolytic, and antidepressant properties. Buy Emylcamate with fast delivery worldwide<\/p>\n

Price:<\/p>\n

Emylcamate 5 g 85 $\u00a0Add to cart<\/b><\/a><\/span>
\n<\/strong><\/p>\n

Emylcamate 10g 150 $\u00a0Add to cart<\/b><\/a><\/span>
\n<\/strong><\/p>\n

Emylcamate\u00a050g 250 $\u00a0Add to cart<\/b><\/a>\u00a0<\/b><\/span>Free shipping<\/span><\/span><\/b>!<\/b><\/strong><\/p>\n

Emylcamate\u00a0100g 390 $\u00a0Add to cart <\/b><\/a><\/span><\/strong>Free shipping<\/span><\/span>!<\/strong><\/p>\n

Emylcamate 500g 1700 $\u00a0Add to cart <\/b><\/a><\/span><\/strong>Free shipping<\/span><\/span>!<\/strong><\/p>\n

Emylcamate 1 kg 2800 $\u00a0Add to cart<\/span> <\/b><\/a><\/strong>Free shipping<\/span><\/span>!<\/strong><\/p>\n

You can buy emylcamate online in our store right now<\/span><\/h3>\n

Emylcamate is a new designer drug designed for research and forensics.<\/span><\/span><\/p>\n

Toxicological and physiological properties of Emylcamate have not been studied.<\/span><\/p>\n

Emylcamate synthesized in the modern laboratory in compliance with all standards.<\/span><\/p>\n

Emylcamate is a new designer drug designed for research and forensics.<\/span><\/span><\/p>\n

Storage conditions: in a cool and dry place.<\/span>
\nStorage time: up to 2 years subject to proper storage conditions.<\/span><\/p>\n

\"Emylcamate\"<\/a><\/span>
Emylcamate<\/span><\/figcaption><\/figure>\n
<\/figcaption><\/figure>\n\n\n\n\n\n\n\n\n\n
Synonyms<\/strong><\/span><\/td>\n\n
    \n
  • Emylcamate;<\/span><\/li>\n
  • Emilcamato;<\/span><\/li>\n
  • Emylcamat;<\/span><\/li>\n
  • Nuncital;<\/span><\/li>\n
  • Psicoplegil;<\/span><\/li>\n
  • Restetal;<\/span><\/li>\n
  • Stratran;<\/span><\/li>\n
  • Striatan;<\/span><\/li>\n
  • Striatran;<\/span><\/li>\n
  • Statran;<\/span><\/li>\n
  • KABI-925;<\/span><\/li>\n
  • Kabi-295;<\/span><\/li>\n
  • tert-Hexyl carbamate;<\/span><\/li>\n
  • MK-250.<\/span><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
IUPAC<\/strong><\/span><\/td>\n\u00a0\u00a0\u00a03-methyl-3-pentanol carbamate<\/span><\/td>\n<\/tr>\n
Formula<\/strong><\/span><\/td>\n\u00a0\u00a0 C7H15NO2<\/span><\/td>\n<\/tr>\n
Molecular weight<\/strong><\/span><\/td>\n\u00a0\u00a0\u00a0145.202 g\u2022mol\u22121<\/span><\/span><\/td>\n<\/tr>\n
CAS<\/strong><\/span><\/td>\n\u00a0\u00a0\u00a078-28-4<\/span><\/span><\/td>\n<\/tr>\n
Appearance<\/strong><\/span><\/td>\n\u00a0\u00a0 Crystalline solid<\/span><\/td>\n<\/tr>\n
Purity<\/strong><\/span><\/td>\n\u00a0\u00a0 \u2265 98%<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

-Choose your favorite products from Chemsaxis<\/strong>, and you are guaranteed excellent quality at the best price.<\/span><\/span><\/p>\n

-Envelopes are sent 24 hours after payment.<\/span>
\nDelivery time 3-4 business days.<\/span>
\n100% delivery speed throughout Europe.<\/span><\/p>\n

-You must know the legal status of the product you order in your country.<\/span>
\n-When ordering on our website from 250 US dollars, delivery at our expense.<\/span>\u00a0The manager automatically excludes shipping costs when ordering from $ 250.<\/span><\/span><\/p>\n

\n

Best Research and Industrial Application Scenarios for buying Emylcamate<\/span><\/h2>\n<\/div>\n
\n
\n

Acute Rapid-Onset Neurological Modeling<\/span><\/h3>\n

Due to its 3-minute intra-parenteral onset\u2014compared to the 35-minute delay of meprobamate\u2014Emylcamate is the preferred carbamate standard for acute in vivo models requiring immediate GABA-A receptor modulation. This rapid pharmacokinetic profile allows researchers to capture early-stage CNS depression metrics without the interference of slow drug absorption [1<\/a>].<\/span><\/p>\n

Dose-Optimized CNS Depression Assays<\/span><\/h3>\n

Emylcamate\u2019s higher potency (63% motor activity reduction at 50 mg\/kg) and wider therapeutic index (TI = 4.4) make it an ideal candidate for dose-escalation studies where minimizing solvent load is critical. Formulators can achieve target efficacy at lower concentrations, thereby reducing the risk of vehicle-induced toxicity in sensitive animal models [1<\/a>].<\/span><\/p>\n

Sterically Hindered Carbamate Stability Testing<\/span><\/h3>\n

As a tertiary alcohol carbamate, Emylcamate serves as an excellent structural baseline for process chemists studying the hydrolysis resistance and stability of sterically hindered esters. Its distinct synthesis requirements and steric profile provide a valuable contrast when evaluating the degradation kinetics of primary or secondary carbamates under varying pH or enzymatic conditions [2<\/a>].<\/span><\/p>\n

Lipid-Based Formulation and Co-Solvent Delivery Optimization<\/span><\/h3>\n

Given its specific LogP of 2.36 and limited aqueous solubility (~0.03 M), Emylcamate is highly suitable for research focused on optimizing lipid-based drug delivery systems or organic co-solvent formulations. It acts as a reliable model compound for testing the solubilizing efficiency of DMSO, ethanol, and glycol ethers in pharmaceutical development workflows .<\/span><\/p>\n

\n
\n

Application Fit Matrix<\/span><\/h3>\n
\n
\n
Application<\/span><\/div>\n
Selection Property<\/span><\/div>\n
Validation Focus<\/span><\/div>\n<\/div>\n
\n
Comparative Carbamate Pharmacology<\/span><\/div>\n
Defined potency & onset kinetics relative to meprobamate<\/span><\/div>\n
Behavioral dose-response and time-course model endpoints<\/span><\/div>\n<\/div>\n
\n
Analytical Method Validation<\/span><\/div>\n
Unique MS behavior and established retention index<\/span><\/div>\n
Compound-specific detection and method robustness review<\/span><\/div>\n<\/div>\n
\n
Spasticity & Cross-Resistance Models<\/span><\/div>\n
Reported differential response in treatment-resistant populations<\/span><\/div>\n
Spasticity model endpoint interpretation and mechanism review<\/span><\/div>\n<\/div>\n
\n
Drug Development Case Study<\/span><\/div>\n
Documented preclinical differentiation and pharmacopoeia history<\/span><\/div>\n
Teaching and reference standard collection context<\/span><\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n
\n

References<\/h3>\n